Humoral and cellular immunity to SARS-CoV-2 vaccination in renal transplant versus dialysis patients: A prospective, multicenter observational study using mRNA-1273 or BNT162b2 mRNA vaccine

被引：238

作者：

Stumpf, Julian ^{[1
,40
]}

Siepmann, Torsten ^{[2
]}

Lindner, Tom ^{[3
]}

Karger, Claudia ^{[4
]}

Schwoebel, Joerg ^{[5
]}

Anders, Leona ^{[6
]}

Faulhaber-Walter, Robert ^{[7
]}

Schewe, Jens ^{[8
]}

Martin, Heike ^{[9
]}

Schirutschke, Holger ^{[10
]}

Barnett, Kerstin ^{[11
]}

Huether, Jan ^{[12
]}

Mueller, Petra ^{[13
]}

Langer, Torsten ^{[14
]}

Pluntke, Thilo ^{[15
]}

Anding-Rost, Kirsten ^{[16
]}

Meistring, Frank ^{[17
]}

Stehr, Thomas ^{[18
]}

Pietzonka, Annegret ^{[19
]}

Escher, Katja ^{[20
]}

Cerny, Simon ^{[21
]}

Rothe, Hansjorg ^{[22
]}

Pistrosch, Frank ^{[23
]}

Seidel, Harald ^{[24
]}

Paliege, Alexander ^{[1
]}

Beige, Joachim ^{[4
,25
]}

Bast, Ingolf ^{[6
]}

Steglich, Anne ^{[1
]}

Gembardt, Florian ^{[1
]}

Kessel, Friederike ^{[1
]}

Kroeger, Hannah ^{[1
]}

Arndt, Patrick ^{[1
]}

Sradnick, Jan ^{[1
]}

Frank, Kerstin ^{[26
]}

Klimova, Anna ^{[27
]}

Mauer, Rene ^{[28
]}

Graehlert, Xina ^{[29
]}

Anft, Moritz ^{[30
,31
]}

Blazquez-Navarro, Arturo ^{[30
,31
]}

Westhoff, Timm H. ^{[32
]}

Stervbo, Ulrik ^{[30
,31
]}

Tonn, Torsten ^{[33
,34
]}

Babel, Nina ^{[30
,31
,35
,36
,37
,38
,39
]}

Hugo, Christian ^{[1
,40
]}

机构：

[1] Tech Univ Dresden, Univ Klinikum Carl Gustav Carus, Med Klin & Poliklin 3, Dresden, Germany

[2] Krankenhaus Kuhwald, KfH Nierenzentrum, Klinikum Chemnitz, Dresden, Germany

[3] Univ Hosp Leipzig, Div Nephrol, Leipzig, Germany

[4] Klinikum St Georg, KfH Nierenzentrum, Leipzig, Germany

[5] Dialysezenturm Chemnitz, Chemnitz, Germany

[6] Dialysepraxis Leipzig, Leipzig, Germany

[7] Nephrol Zentrum Freiberg, Freiberg, Germany

[8] Dialyse & Nierenambulanz Sebnitz, Sebnitz, Germany

[9] Nephrol Zentrum Zwickau, Zwickau, Germany

[10] PHV Dialysezentrum Dresden Friedrichstadt, Dresden, Germany

[11] Dialyse Heidenau, Heidenau, Germany

[12] Nephrocare GmbH Dobeln, Dobeln, Germany

[13] PHV Dialysezentrum Dresden Johannstadt, Dresden, Germany

[14] Dialysezentrum Annaberg, Annaberg Buchholz, Germany

[15] KfH Nierenzentrum Grimma, Grimma, Germany

[16] KfH Nierenzentrum Bischofswerda, Bischofswerda, Germany

[17] Stadt Klinikum Gorlitz, KfH Nierenzentrum, Gorlitz, Germany

[18] KfH Nierenzentrum Bautzen, Bautzen, Germany

[19] Via Medis Nierenzentrum Dresden MVZ GmbH, Dresden, Germany

[20] KfH Gesundheitszentrum Aue, Aue Bad Schlema, Germany

[21] ELBLAND Dialyse Grossenhain, Grossenhain, Germany

[22] Dialyse Praxis Weiwasser, Weiwasser, Germany

[23] Nephrol Zentrum Hoyerswerda, Hoyerswerda, Germany

[24] Vogtland Krankenhaus Plauen, KfH Nierenzentrum, Plauen, Germany

[25] Martin Luther Univ Halle Wittenberg, Dept Nephrol & Rheumatol, Internal Med 2, Halle, Germany

[26] DRK Blutspendedienst Nord Ost Gemeinnutzige GmbH, Inst Transfus Med Plauen, Plauen, Germany

[27] Natl Ctr Tumor Dis NCT, Partner Site Dresden, Dresden, Germany

[28] Tech Univ, Fac Med Carl Gustav Carus, Inst Med Informat & Biometry IMB, Dresden, Germany

[29] Coordinating Ctr Clin Trials, Dresden, Germany

[30] Ruhr Univ Bochum, Ctr Translat Med, Med Dept 1, Marien Hosp Herne,Univ Hosp, Bochum, Germany

[31] Ruhr Univ Bochum, Univ Hosp, Marien Hosp Herne, Med Dept 1,Immune Diagnost Lab, Bochum, Germany

[32] Ruhr Univ Bochum, Marien Hosp Herne, Med Dept 1, Univ Hosp, Herne, Germany

[33] German Red Cross Blood Donat Serv North East, Inst Transfus Med, Dresden, Germany

[34] Tech Univ, Fac Med Carl Gustav Carus, Transfus Med, Dresden, Germany

[35] Charite Univ Med Berlin, Berlin Brandenburg Ctr Regenerat Therapies, Berlin, Germany

[36] Free Univ Berlin, Berlin, Germany

[37] Humboldt Univ, Berlin, Germany

[38] Berlin Inst Hlth, Berlin, Germany

[39] Inst Med Immunol, Berlin, Germany

[40] KfH Nierenzentrum Dresden, Dresden, Germany

来源：

LANCET REGIONAL HEALTH-EUROPE | 2021年 / 9卷

关键词：

epidemiology; COVID-19; SARS-CoV-2; vaccination; mRNA-1273; BNT162b2; tozinameran; dialysis patients; kidney transplant recipients; medical personnel; humoral and cellular immune response; clinical decision-making; guidelines; COVID-19; RECIPIENTS; SPIKE;

D O I：

10.1016/j.lanepe.2021.100178

中图分类号：

R19 [保健组织与事业（卫生事业管理）];

学科分类号：

摘要：

Background: Dialysis and kidney transplant patients are vulnerable populations for COVID-19 related disease and mortality. Methods: We conducted a prospective study exploring the eight week time course of specific cellular (interferon-g release assay and flow cytometry) or/and humoral immune responses (ELISA) to SARS-CoV-2 boost vaccination in more than 3100 participants including medical personnel, dialysis patients and kidney transplant recipients using mRNA vaccines BNT162b2 or mRNA-1273. Results: SARS-CoV-2-vaccination induced seroconversion efficacy in dialysis patients was similar to medical personnel (> 95%), but markedly impaired in kidney transplant recipients (42%). T-cellular immunity largely mimicked humoral results. Major risk factors of seroconversion failure were immunosuppressive drug number and type (belatacept, MMF-MPA, calcineurin-inhibitors) as well as vaccine type (BNT162b2 mRNA). Seroconversion rates induced by mRNA-1273 compared to BNT162b2 vaccine were 97% to 88% (p < 0.001) in dialysis and 49% to 26% in transplant patients, respectively. Specific IgG directed against the new binding domain of the spike protein (RDB) were significantly higher in dialysis patients vaccinated by mRNA-1273 (95%) compared to BNT162b2 (85%, p < 0.001). Vaccination appeared safe and highly effective demonstrating an almost complete lack of symptomatic COVID-19 disease after boost vaccination as well as ceased disease incidences during third pandemic wave in dialysis patients. Conclusion: Dialysis patients exhibit a remarkably high seroconversion rate of 95% after boost vaccination, while humoral response is impaired in the majority of transplant recipients. Immunosuppressive drug number and type as well as vaccine type (BNT162b2) are major determinants of seroconversion failure in both dialysis and transplant patients suggesting immune monitoring and adaption of vaccination protocols. (C) 2021 The Authors. Published by Elsevier Ltd.

引用

页数：11

共 50 条

[1] Comparison of mRNA-1273 and BNT162b2 SARS-CoV-2 mRNA Vaccine Immunogenicity in Kidney Transplant Recipients
Haller, Maria C.
Kaiser, Robert A.
Langthaler, Simon
Brandstetter, Clara
Apfalter, Petra
Kerschner, Heidrun
Cejka, Daniel
TRANSPLANT INTERNATIONAL, 2022, 35
[2] Humoral and Cellular Responses to mRNA-1273 and BNT162b2 SARS-CoV-2 Vaccines Administered to Hemodialysis Patients
Broseta, Jose Jesus
Espinosa, Diana Rodriguez-
Rodriguez, Nestor
Mosquera, Maria del Mar
Angeles Marcos, Maria
Egri, Natalia
Pascal, Mariona
Soruco, Erica
Bedini, Jose Luis
Bayes, Beatriu
Maduell, Francisco
AMERICAN JOURNAL OF KIDNEY DISEASES, 2021, 78 (04) : 571 - 581
[3] Cellular and Humoral Responses in Dialysis Patients after Vaccination with the BNT162b2 or mRNA-1273 Vaccines
Mavrovouniotis, Ilias
Fylaktou, Asimina
Stagou, Maria
Ouranos, Konstantinos
Lioulios, Georgios
Evgenikaki, Efthimia
Exindari, Maria
Gioula, Georgia
LIFE-BASEL, 2023, 13 (02):
[4] Humoral and cellular response to SARS-CoV-2 BNT162b2 mRNA vaccine in hemodialysis patients
Melin, Jan
Svensson, Maria K.
Albinsson, Bo
Winqvist, Ola
Pauksens, Karlis
BMC IMMUNOLOGY, 2021, 22 (01)
[5] Humoral and cellular response to SARS-CoV-2 BNT162b2 mRNA vaccine in hemodialysis patients
Jan Melin
Maria K. Svensson
Bo Albinsson
Ola Winqvist
Karlis Pauksens
BMC Immunology, 22
[6] Humoral Immune Response in IBD Patients Three and Six Months after Vaccination with the SARS-CoV-2 mRNA Vaccines mRNA-1273 and BNT162b2
Vollenberg, Richard
Tepasse, Phil-Robin
Kuehn, Joachim Ewald
Hennies, Marc
Strauss, Markus
Rennebaum, Florian
Schomacher, Tina
Boeckel, Goeran
Lorentzen, Eva
Bokemeyer, Arne
Nowacki, Tobias Max
BIOMEDICINES, 2022, 10 (01)
[7] Humoral Response after Three Doses of mRNA-1273 or BNT162b2 SARS-CoV-2 Vaccines in Hemodialysis Patients
Jesus Broseta, Jose
Rodriguez-Espinosa, Diana
Cuadrado, Elena
Rodriguez, Nestor
Luis Bedini, Jose
Maduell, Francisco
VACCINES, 2022, 10 (04)
[8] Experience with SARS-CoV-2 BNT162b2 mRNA vaccine in dialysis patients
Yanay, Noa Berar
Freiman, Sarit
Shapira, Ma'anit
Wishahi, Samar
Hamze, Munir
Elhaj, Mohamad
Zaher, Maha
Armaly, Zaher
KIDNEY INTERNATIONAL, 2021, 99 (06) : 1496 - 1498
[9] Predictors of humoral response to SARS-CoV-2 mRNA vaccine BNT162b2 in patients receiving maintenance dialysis
Li, Tingting
Gandra, Sumanth
Reske, Kimberly A.
Olsen, Margaret A.
Bommarito, Silvana
Miller, Candace
Hock, Karl G.
Ballman, Claire A.
Su, Christina
Le Dang, Na
Kwon, Jennie H.
Warren, David K.
Fraser, Victoria J.
Farnsworth, Christopher W.
ANTIMICROBIAL STEWARDSHIP & HEALTHCARE EPIDEMIOLOGY, 2022, 2 (01):
[10] Myocarditis After BNT162b2 and mRNA-1273 Vaccination
Larson, Kathryn F.
Ammirati, Enrico
Adler, Eric D.
Cooper, Leslie T., Jr.
Hong, Kimberly N.
Saponara, Gianluigi
Couri, Daniel
Cereda, Alberto
Procopio, Antonio
Cavalotti, Cristina
Oliva, Fabrizio
Sanna, Tommaso
Ciconte, Vincenzo Antonio
Onyango, George
Holmes, David R.
Borgeson, Daniel D.
CIRCULATION, 2021, 144 (06) : 506 - 508

← 1 2 3 4 5 →